Recent evidence suggests that ARID1A may have a role in progesterone insensitivity, as loss of ARID1a led to reduced expression of PGR in human endometrial cell lines, mouse models, and clinical tumour tissues [63,64]. The gene discussed is ARID1A; the disease is neoplasm.